Paying users zone. Data is covered by .

  • Get to Celgene Corp. for $13.99, or

  • get to whole website for at least 3 months from $49.99.

 

$13.99

Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Celgene Corp., Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

USD $ in millions

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Short-term borrowings and current portion of long-term debt
Accounts payable
Rebates, distributor chargebacks and distributor services
Compensation
Clinical trial costs and grants
Litigation-related loss contingency
Interest
Sales, use, value added, and other taxes
Contingent consideration
Milestones payable
Deferred tax liability
Other
Accrued expenses and other current liabilities
Income taxes payable
Current portion of deferred revenue
Current liabilities
Deferred revenue, net of current portion
Income taxes payable
Deferred income tax liabilities
Other non-current tax liabilities
Contingent consideration
Deferred compensation and long-term incentives
Contingent value rights
Derivative contracts
Other
Other non-current liabilities
Long-term debt, net of discount, excluding current portion
Non-current liabilities
Total liabilities
Preferred stock, $.01 par value per share; none outstanding
Common stock, $.01 par value per share
Common stock in treasury, at cost
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Stockholders' equity
Total liabilities and stockholders' equity
Source: Celgene Corp., Annual Reports
Item Description The company
Accounts payable Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Celgene Corp.'s accounts payable increased from 2015 to 2016 and from 2016 to 2017.
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Celgene Corp.'s current liabilities increased from 2015 to 2016 and from 2016 to 2017.
Non-current liabilities Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle. Celgene Corp.'s non-current liabilities declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Celgene Corp.'s total liabilities increased from 2015 to 2016 and from 2016 to 2017.
Stockholders' equity Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). Celgene Corp.'s stockholders' equity increased from 2015 to 2016 and from 2016 to 2017.

Top